YP.Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. Am J Physiol Endocrinol Metab 299: E189 -E197, 2010. First published May 11, 2010; doi:10.1152/ajpendo.00516.2009.-Carboxypeptidase E (CPE) is a prohormone/proneuropeptide processing enzyme, and mice bearing CPE mutations exhibit an obese and diabetic phenotype. Studies on CPE knockout (KO) mice revealed poor prohormone processing, resulting in deficiencies in peptide hormones/neuropeptides such as insulin, gonadotropin-releasing hormone, and cocaineand amphetamine-regulated transcript (CART). Here, we show that CPE KO mice, an obese animal model, have low bone mineral density (BMD) accompanied by elevated plasma CTX-1 (carboxy-terminal collagen crosslinks), and osteocalcin, indicators of increased bone turnover. Receptor activator for NF-B ligand (RANKL) expression was elevated ϳ2-fold relative to osteoprotegerin in the femur of KO animals, suggesting increased osteoclastic activity in the KO mice. In the hypothalamus, mature CART, a peptide involved in eating behavior and implicated in bone metabolism, was undetectable. The melanocortin and neuropeptide Y (NPY) systems in the hypothalamus have also been implicated in bone remodeling, since MC4R KO and NPY KO mice have increased BMD. However, reduction of ␣-MSH, the primary ligand of MC4R by up to 94% and the lack of detectable NPY in the hypothalamus of CPE KO do not recapitulate the singlegene KO phenotypes. This study highlights the complex physiological interplay between peptides involved in energy metabolism and bone formation and furthermore suggests the possibility that patients, bearing CPE and CART mutations leading to inactive forms of these molecules, may be at a higher risk of developing osteoporosis. CARBOXYPEPTIDASE E (CPE) is a processing enzyme that is highly expressed in endocrine cells and peptidergic neurons (17,19). It functions to cleave carboxy-terminally extended lysine and arginine residues from peptide hormone and neuropeptide intermediates to form bioactive peptides in the regulated secretory pathway (RSP). In addition to its enzymatic function, CPE has been shown to facilitate trafficking of several prohormones into the granules of the RSP (10, 26). Recently, live-cell imaging and coimmunoprecipitation studies demonstrated a role for its cytoplasmic carboxyl terminus in the transport of peptidergic vesicles via interaction with dynactin, an anterograde microtubule-based motor protein complex (27,28). The involvement of CPE in multiple cellular functions would suggest that deficiencies in CPE would lead to many pathologies. Indeed, the CPE knockout (KO) mouse exhibits multiple endocrinopathies leading to diabetes, infertility, and obesity (7).During our initial characterization of the phenotype of the CPE KO mice, which included physical and biochemical measurements as well as behavioral tests (7), we observed unexpectedly that bone mineral density (BMD) measurements of the CPE KO mice were lower th...